309 related articles for article (PubMed ID: 2971691)
21. Skin manifestations in AIDS, HIV infection, and AIDS-related complex.
Sindrup JH; Lisby G; Weismann K; Wantzin GL
Int J Dermatol; 1987 Jun; 26(5):267-72. PubMed ID: 2956207
[No Abstract] [Full Text] [Related]
22. Case definitions for paediatric AIDS: the Zambian experience.
Chintu C; Malek A; Nyumbu M; Luo C; Masona J; DuPont HL; Zumla A
Int J STD AIDS; 1993; 4(2):83-5. PubMed ID: 8476970
[TBL] [Abstract][Full Text] [Related]
23. Dermatologic manifestations among human immunodeficiency virus patients in south India.
Kumarasamy N; Solomon S; Madhivanan P; Ravikumar B; Thyagarajan SP; Yesudian P
Int J Dermatol; 2000 Mar; 39(3):192-5. PubMed ID: 10759958
[TBL] [Abstract][Full Text] [Related]
24. [Cutaneous manifestations of AIDS].
Marrakchi H; Mokhtar I; Zarrouk H; Daghfous M; Kamoun MR
Tunis Med; 1993 Mar; 71(3):119-22. PubMed ID: 8351723
[TBL] [Abstract][Full Text] [Related]
25. Adverse cutaneous reactions to thiacetazone for tuberculosis treatment in Tanzania.
Ipuge YA; Rieder HL; Enarson DA
Lancet; 1995 Sep; 346(8976):657-60. PubMed ID: 7544858
[TBL] [Abstract][Full Text] [Related]
26. Skin conditions common to people with HIV infection or AIDS.
Kalibala S
AIDS Action; 1990 Apr; (10):2-3. PubMed ID: 12342834
[TBL] [Abstract][Full Text] [Related]
27. Some clinical aspects of HIV infection in Africa.
Harries A
Afr Health; 1992 Jul; 14(5):10-1. PubMed ID: 12317768
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous manifestations of human immunodeficiency virus infection in Taiwan.
Tzung TY; Yang CY; Chao SC; Lee JY
Kaohsiung J Med Sci; 2004 May; 20(5):216-24. PubMed ID: 15233232
[TBL] [Abstract][Full Text] [Related]
29. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
[TBL] [Abstract][Full Text] [Related]
30. [Prevalence of skin manifestations in AIDS patients in the Lome-Tokoin University Hospital (Togo)].
Pitche P; Tchangaï-Walla K; Napo-Koura G; Mijiyawa M; Agbere A; Tatagan A
Sante; 1995; 5(6):349-52. PubMed ID: 8784537
[TBL] [Abstract][Full Text] [Related]
31. [Skin manifestations in patients with HIV infection].
Eichmann A
Z Hautkr; 1990 Jul; 65(7):640-4. PubMed ID: 2205061
[TBL] [Abstract][Full Text] [Related]
32. [Skin diseases disclosing human immunodeficiency virus infection in Mali].
Mahé A; Bobin P; Coulibaly S; Tounkara A
Ann Dermatol Venereol; 1997; 124(2):144-50. PubMed ID: 9740824
[TBL] [Abstract][Full Text] [Related]
33. Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.
Hawken M; Nunn P; Gathua S; Brindle R; Godfrey-Faussett P; Githui W; Odhiambo J; Batchelor B; Gilks C; Morris J
Lancet; 1993 Aug; 342(8867):332-7. PubMed ID: 7687729
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness and total costs of three alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of Human Immunodeficiency Virus positive patients with tuberculosis in Kenya.
van Gorkom J; Kibuga DK
Tuber Lung Dis; 1996 Feb; 77(1):30-6. PubMed ID: 8733411
[TBL] [Abstract][Full Text] [Related]
35. Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals.
Ambrus JL; Poiesz BJ; Lillie MA; Stadler I; Di Berardino LA; Chadha KC
Am J Med; 1989 Oct; 87(4):405-7. PubMed ID: 2478016
[TBL] [Abstract][Full Text] [Related]
36. Dermatoses among Brazilian HIV-positive patients: correlation with the evolutionary phases of AIDS.
Rosatelli JB; Machado AA; Roselino AM
Int J Dermatol; 1997 Oct; 36(10):729-34. PubMed ID: 9372345
[TBL] [Abstract][Full Text] [Related]
37. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse.
Muñoz-Pérez MA; Rodriguez-Pichardo A; Camacho F; Colmenero MA
Br J Dermatol; 1998 Jul; 139(1):33-9. PubMed ID: 9764146
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis.
Nunn P; Kibuga D; Gathua S; Brindle R; Imalingat A; Wasunna K; Lucas S; Gilks C; Omwega M; Were J
Lancet; 1991 Mar; 337(8742):627-30. PubMed ID: 1705647
[TBL] [Abstract][Full Text] [Related]
40. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomised double blind controlled trial.
Kelly P; Lungu F; Keane E; Baggaley R; Kazembe F; Pobee J; Farthing M
BMJ; 1996 May; 312(7040):1187-91. PubMed ID: 8634560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
